15 results on '"Chong, Shan"'
Search Results
2. Evaluation of clinical factors and outcome of systemic glucocorticoid therapy discontinuation in patients with pemphigus achieving complete remission
- Author
-
Wang, Mingyue, primary, Li, Jiaqi, additional, Shang, Panpan, additional, Chong, Shan, additional, Chen, Yan, additional, Zhao, Liuqi, additional, Wang, Rui, additional, Fan, Birao, additional, Li, Furong, additional, Chen, Xi, additional, Zhang, Yuexin, additional, Zhao, Junyu, additional, Dang, Jingyang, additional, Chen, Xixue, additional, and Zhu, Xuejun, additional
- Published
- 2023
- Full Text
- View/download PDF
3. The optimization of plasma activated water ( PAW ) generation and the inactivation mechanism of PAW on Escherichia coli
- Author
-
Han, Qian‐Yun, primary, He, Zheng‐Yu, additional, Zhong, Chong‐Shan, additional, Wen, Xin, additional, and Ni, Yuan‐Ying, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Elastic‐inertial separation of microparticle in a gradually contracted microchannel
- Author
-
Tian, Zhuang‐Zhuang, primary, Gan, Chong‐Shan, additional, Fan, Liang‐Liang, additional, Wang, Ji‐Chang, additional, and Zhao, Liang, additional
- Published
- 2022
- Full Text
- View/download PDF
5. Geriatric syndromes and quality of life in older adults with diabetes
- Author
-
Yi Ching Yang, Jin Shang Wu, Hui Ping Cheng, Chong Shan Wang, Ming Hsing Lin, Feng Hwa Lu, and Sang I. Lin
- Subjects
Male ,Sleep Wake Disorders ,medicine.medical_specialty ,Activities of daily living ,Taiwan ,Urinary incontinence ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,030502 gerontology ,Diabetes Mellitus ,medicine ,Humans ,Cognitive Dysfunction ,Mobility Limitation ,Brief Pain Inventory ,Geriatric Assessment ,Depression (differential diagnoses) ,Aged ,Pain Measurement ,Aged, 80 and over ,Polypharmacy ,Sleep disorder ,Depression ,business.industry ,Syndrome ,medicine.disease ,Urinary Incontinence ,Quality of Life ,Physical therapy ,Accidental Falls ,Female ,Geriatric Depression Scale ,Independent Living ,medicine.symptom ,0305 other medical science ,business ,030217 neurology & neurosurgery - Abstract
AIM To describe geriatric syndromes and their relationships with quality of life in older adults with diabetes. METHODS Community-dwelling older adults (aged >60 years) with diabetes (n = 316) participated in the present study. Eight geriatric syndromes, including polypharmacy (number of medications), pain (Brief Pain Inventory), urinary incontinence (International Consultation on Incontinence Questionnaire), sleep disturbance (hours of sleep), lower cognitive level (Mini-Mental State Examination), falls, depressive symptoms (Geriatric Depression Scale short form) and functional limitation (Barthel Index and Instrumental Activity of Daily Living), were assessed. The WHOQOL-BREF Taiwan version was used to measure physical, psychological, social and environmental domains of quality of life. RESULTS Polypharmacy was the most common geriatric syndrome (46.6%), followed by pain (41.5%). Participants with any of the geriatric syndromes, except for polypharmacy and sleep disturbance, had significantly poorer quality of life than those without. The Geriatric Depression Scale score was the only common and significant contributor to all four domains of quality of life, explaining 16~29% of the variance. Number of medications, pain level and cognitive level were also significant contributors, although they explained a small amount (
- Published
- 2019
6. Geriatric syndromes and quality of life in older adults with diabetes
- Author
-
Yang, Yi‐Ching, primary, Lin, Ming‐Hsing, additional, Wang, Chong‐Shan, additional, Lu, Feng‐Hwa, additional, Wu, Jin‐Shang, additional, Cheng, Hui‐Ping, additional, and Lin, Sang‐I, additional
- Published
- 2019
- Full Text
- View/download PDF
7. Influnece of an occlusal splint on integrated electromyography of the masseter muscles
- Author
-
Shi Chong Shan and Wang Hui Yun
- Subjects
Adult ,Male ,musculoskeletal diseases ,medicine.medical_treatment ,Dentistry ,Electromyography ,Dental Occlusion ,Masseter muscle ,Humans ,Medicine ,General Dentistry ,medicine.diagnostic_test ,Masseter Muscle ,business.industry ,Temporomandibular Joint Dysfunction Syndrome ,Temporomandibular joint ,Masticatory force ,body regions ,medicine.anatomical_structure ,Splints ,Bruxism ,Female ,business ,Splint (medicine) ,Muscle Contraction - Abstract
Summary In order to examine the effect of an occlusal splint on the integrated electromyography (EMG) of the masticatory muscles, EMG of bilateral masseter muscles of 23 patients with temporomandibular joint distrubance syndrome (TMJDS), with and without an occlusal spint, was measured and integrated on line during maximum clenching. It was found that the integrated myoelectrical value of the masseter muscle on the involved and non-involved side was reduced with the occlusal splint. The absolute difference between integrated myoelectrical values in the left and right masseter muscles was reduced with an occlusal spint, but the relative difference remained virtually unchanged. These results indicate that the occlusal splint can decrease masseter muscle activity and thus exert a therapeutic effect.
- Published
- 1991
8. Power spectral analysis of occlusal sounds of natural dentition subjects
- Author
-
CHONG-SHAN, SHI, primary, GUAN, OUYANG, additional, and TIAN-WEN, GUO, additional
- Published
- 1991
- Full Text
- View/download PDF
9. Comparison of food particle distribution masticated by subjects wearing complete dentures and with natural teeth
- Author
-
CHONG-SHAN, SHI, primary, GUAN, OUYANG, additional, and TIAN-WEN, GUO, additional
- Published
- 1990
- Full Text
- View/download PDF
10. Value of EMG analysis of mandibular elevators in open-close-clench cycle to diagnosing TMJ disturbance syndrome
- Author
-
S. Chong-Shan and W. Hui-Yun
- Subjects
Adult ,Male ,Time Factors ,Therapeutic effectiveness ,Temporal Muscle ,Mandible ,Dental Occlusion ,Masseter muscle ,stomatognathic system ,medicine ,Humans ,General Dentistry ,Orthodontics ,Electromyography ,Masseter Muscle ,business.industry ,Anatomy ,Temporomandibular Joint Dysfunction Syndrome ,Temporomandibular joint ,medicine.anatomical_structure ,Splints ,Masticatory Muscles ,Contact position ,Female ,Silent period ,medicine.symptom ,business ,After treatment ,Muscle Contraction ,Muscle contraction - Abstract
Summary The EMGs of the temporal and masseter muscle, in sixty patients with temporomandibular joint disturbance syndrome (TMJDS) and thirty normal controls, were recorded during rhythmical open-close-clench cycle movement and before and after occlusal splint therapy. The duration of the muscle contraction before initial tooth contact (DMC), the latent period (LP) and the silent period (SP) of the myoelectrical activity were used as indices for exploring their diagnostic value. In contrast with the controls, DMC, LP and SP lengthened in the patients. The DMC was prolonged in those patients where there were TMJ sounds, the inter-cuspated position did not coincide with the muscular contact position and there was deviated mandibular movement. An increase of the SP was related to tooth contact on the balancing side. After treatment, the DMC and SP in the patients returned to the level of the controls. It was found that the internal correction rate of Fisher's linear discriminate function established for the DMC and SP of the temporal and masseter muscles was 80.9% and 85.1% respectively. The results show that the DMC and SP of the temporal and masseter muscles have some value in diagnosing muscular dysfunction and discriminating therapeutic effectiveness.
- Published
- 1989
11. Postural and maximum activity in elevators during mandible pre- and post-occlusal splint treatment of temporomandibular joint disturbance syndrome
- Author
-
Shi Chong-Shan and Wang Hui-Yun
- Subjects
Adult ,Male ,musculoskeletal diseases ,medicine.medical_treatment ,Dentistry ,Temporal Muscle ,Mandible ,Isometric exercise ,Electromyography ,Dental Occlusion ,stomatognathic system ,Isometric Contraction ,Reflex ,medicine ,Humans ,General Dentistry ,Pre and post ,medicine.diagnostic_test ,Masseter Muscle ,Dental occlusion ,business.industry ,Temporomandibular Joint Dysfunction Syndrome ,Temporomandibular joint ,stomatognathic diseases ,Splints ,medicine.anatomical_structure ,Masticatory Muscles ,Female ,Splint (medicine) ,business - Abstract
Electromyograms (EMGs) of the temporal and masseter muscles in sixty patients with temporomandibular joint disturbance syndrome (TMJDS) and thirty controls were recorded and integrated on-line in the postural position and during maximum clenching, before and after occlusal splint therapy. Contrasting with the controls, the myoelectrical activity of the patients was higher in the postural position and lower during maximum clenching, whilst the former in percentage terms increased when compared to the latter. After treatment, the EMG indexes in some patients returned partially, and in others completely, to a normal level. Tenderness in the mandibular elevators, deviated opening and organic change in the TMJ increased the postural myoelectrical activity, in percentage terms, against that of maximum clenching. The myoelectrical activity of the mandibular elevators in the postural position and during maximum clenching was smaller in patients with the occlusal splint than in those without. The results show that the mandibular elevators in the patients with TMJDS were hyperactive and tense, and that the occlusal splint was useful for treating such dysfunction.
- Published
- 1989
12. Postural and maximum activity in elevators during mandible pre- and post-occlusal splint treatment of temporomandibular joint disturbance syndrome
- Author
-
CHONG-SHAN, SHI, primary and HUI-YUN, WANG, additional
- Published
- 1989
- Full Text
- View/download PDF
13. Value of EMG analysis of mandibular elevators in open‐close‐clench cycle to diagnosing TMJ disturbance syndrome
- Author
-
CHONG‐SHAN, S., primary and HUI‐YUN, W., additional
- Published
- 1989
- Full Text
- View/download PDF
14. Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.
- Author
-
Kong Z, Liang N, Yang GL, Zhang Z, Liu Y, Li J, Liu X, Liang S, Nikolova D, Jakobsen JC, Gluud C, and Liu JP
- Subjects
- Herbal Medicine, Humans, Phytotherapy, Randomized Controlled Trials as Topic, Drugs, Chinese Herbal therapeutic use, Hepatitis B, Chronic drug therapy
- Abstract
Background: Chronic hepatitis B is associated with high morbidity and mortality. Chronic hepatitis B requires long-term management aiming at reduction of the risks of hepatocellular inflammatory necrosis, liver fibrosis, decompensated liver cirrhosis, liver failure, and liver cancer, and improving health-related quality of life. The Chinese herbal medicine formula Xiao Chai Hu Tang has been used to decrease discomfort and replication of the virus in people with chronic hepatitis B. However, the benefits and harms of Xiao Chai Hu Tang formula have never been established with rigorous review methodology., Objectives: To assess the benefits and harms of Xiao Chai Hu Tang formula versus placebo or no intervention in people with chronic hepatitis B., Search Methods: We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, CENTRAL, MEDLINE Ovid, Embase Ovid, and seven other databases to 1 March 2019. We also searched the World Health Organization International Clinical Trials Registry Platform (www.who.int/ictrp), ClinicalTrials.gov (www.clinicaltrials.gov/), and the Chinese Clinical Trial Registry for ongoing or unpublished trials to 1 March 2019., Selection Criteria: We included randomised clinical trials, irrespective of publication status, language, and blinding, comparing Xiao Chai Hu Tang formula versus no intervention or placebo in people with chronic hepatitis B. We included participants of any sex and age, diagnosed with chronic hepatitis B according to guidelines or as defined by the trialists. We allowed co-interventions when the co-interventions were administered equally to all the intervention groups., Data Collection and Analysis: Review authors independently retrieved data from reports and after correspondence with investigators. Our primary outcomes were all-cause mortality, serious adverse events, and health-related quality of life. Our secondary outcomes were hepatitis B-related mortality, hepatitis B-related morbidity, and adverse events considered 'not to be serious'. We presented the meta-analysed results as risk ratios (RR) with 95% confidence intervals (CI). We assessed the risks of bias using risk of bias domains with predefined definitions. We used GRADE methodology to evaluate our certainty in the evidence., Main Results: We included 10 randomised clinical trials with 934 participants, but only five trials with 490 participants provided data for analysis. All the trials compared Xiao Chai Hu Tang formula with no intervention. All trials appeared to have been conducted and published only in China. The included trials assessed heterogeneous forms of Xiao Chai Hu Tang formula, administered for three to eight months. One trial included participants with hepatitis B and comorbid tuberculosis, and one trial included participants with hepatitis B and liver cirrhosis. The remaining trials included participants with hepatitis B only. All the trials were at high risk of bias, and the certainty of evidence for all outcomes that provided data for analyses was very low. We downgraded the evidence by one or two levels because of outcome risk of bias, inconsistency or heterogeneity of results (opposite direction of effect), indirectness of evidence (use of surrogate outcomes instead of clinically relevant outcomes), imprecision of results (the CIs were wide), and publication bias (small sample size of the trials). Additionally, 47 trials lacked the necessary methodological information needed to ensure the inclusion of these trials in our review. None of the included trials aimed to assess clinically relevant outcomes such as all-cause mortality, serious adverse events, health-related quality of life, hepatitis B-related mortality, or hepatitis B-related morbidity. The effects of Xiao Chai Hu Tang formula on the proportion of participants with adverse events considered 'not to be serious' is uncertain (RR 0.43, 95% CI 0.02 to 11.98; I
2 = 69%; very low-certainty evidence). Only three trials with 222 participants reported the proportion of people with detectable hepatitis B virus DNA (HBV-DNA), but the evidence that Xiao Chai Hu Tang formula reduces the presence of HBV-DNA in the blood (a surrogate outcome) is uncertain (RR 0.62, 95% CI 0.45 to 0.85; I2 = 0%; very low-certainty evidence). Only two trials with 160 participants reported the proportion of people with detectable hepatitis B virus e-antigen (HBeAg; a surrogate outcome) (RR 0.72, 95% CI 0.50 to 1.02; I2 = 38%; very low-certainty evidence) and the evidence is uncertain. The evidence is also uncertain for separately reported adverse events considered 'not to be serious'., Funding: two of the 10 included trials received academic funding from government or hospital. None of the remaining eight trials reported information on funding., Authors' Conclusions: The clinical effects of Xiao Chai Hu Tang formula for chronic hepatitis B remain unclear. The included trials were small and of low methodological quality. Despite the wide use of Xiao Chai Hu Tang formula, we lack data on all-cause mortality, serious adverse events, health-related quality of life, hepatitis B-related mortality, and hepatitis B-related morbidity. The evidence in this systematic review comes from data obtained from a maximum three trials. We graded the certainty of evidence as very low for adverse events considered not to be serious and the surrogate outcomes HBeAg and HBV-DNA. We found a large number of trials which lacked clear description of their design and conduct, and hence, these trials are not included in the present review. As all identified trials were conducted in China, there might be a concern about the applicability of this review outside China. Large-sized, high-quality randomised sham-controlled trials with homogeneous groups of participants and transparent funding are lacking., (Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.)- Published
- 2019
- Full Text
- View/download PDF
15. Acupuncture for chronic hepatitis B.
- Author
-
Kong Z, Liang N, Yang GL, Zhang Z, Liu Y, Yang Y, Liu YX, Wang QG, Zhang F, Zhang HY, Nikolova D, Jakobsen JC, Gluud C, and Liu JP
- Subjects
- Humans, Quality of Life, Randomized Controlled Trials as Topic, Treatment Outcome, Acupuncture Therapy methods, Hepatitis B, Chronic therapy
- Abstract
Background: Chronic hepatitis B is a liver disease associated with high morbidity and mortality. Chronic hepatitis B requires long-term management aiming to reduce the risks of hepatocellular inflammatory necrosis, liver fibrosis, decompensated liver cirrhosis, liver failure, and liver cancer, as well as to improve health-related quality of life. Acupuncture is being used to decrease discomfort and improve immune function in people with chronic hepatitis B. However, the benefits and harms of acupuncture still need to be established in a rigorous way., Objectives: To assess the benefits and harms of acupuncture versus no intervention or sham acupuncture in people with chronic hepatitis B., Search Methods: We undertook electronic searches of the Cochrane Hepato-Biliary Group Controlled Trials Register, CENTRAL, MEDLINE, Embase, LILACS, Science Citation Index Expanded, Conference Proceedings Citation Index - Science, China National Knowledge Infrastructure (CNKI), Chongqing VIP (CQVIP), Wanfang Data, and SinoMed to 1 March 2019. We also searched the World Health Organization International Clinical Trials Registry Platform (www.who.int/ictrp), ClinicalTrials.gov (www.clinicaltrials.gov/), and the Chinese Clinical Trial Registry (ChiCTR) for ongoing or unpublished trials until 1 March 2019., Selection Criteria: We included randomised clinical trials, irrespective of publication status, language, and blinding, comparing acupuncture versus no intervention or sham acupuncture in people with chronic hepatitis B. We included participants of any sex and age, diagnosed with chronic hepatitis B as defined by the trialists or according to guidelines. We allowed co-interventions when the co-interventions were administered equally to all intervention groups., Data Collection and Analysis: Review authors in pairs individually retrieved data from reports and through correspondence with investigators. Primary outcomes were all-cause mortality, proportion of participants with one or more serious adverse events, and health-related quality of life. Secondary outcomes were hepatitis B-related mortality, hepatitis B-related morbidity, and adverse events considered not to be serious. We presented the pooled results as risk ratios (RRs) with 95% confidence intervals (CIs). We assessed the risks of bias using risk of bias domains with predefined definitions. We put more weight on the estimate closest to zero effect when results with fixed-effect and random-effects models differed. We evaluated the certainty of evidence using GRADE., Main Results: We included eight randomised clinical trials with 555 randomised participants. All included trials compared acupuncture versus no intervention. These trials assessed heterogeneous acupuncture interventions. All trials used heterogeneous co-interventions applied equally in the compared groups. Seven trials included participants with chronic hepatitis B, and one trial included participants with chronic hepatitis B with comorbid tuberculosis. All trials were assessed at overall high risk of bias, and the certainty of evidence for all outcomes was very low due to high risk of bias for each outcome, imprecision of results (the confidence intervals were wide), and publication bias (small sample size of the trials, and all trials were conducted in China). Additionally, 79 trials lacked the necessary methodological information to ensure their inclusion in our review.None of the included trials aim to assess all-cause mortality, serious adverse events, health-related quality of life, hepatitis B-related mortality, and hepatitis B-related morbidity. We are uncertain whether acupuncture, compared with no intervention, has an effect regarding adverse events considered not to be serious (RR 0.67, 95% CI 0.43 to 1.06; I² = 0%; 3 trials; 203 participants; very low-certainty evidence) or detectable hepatitis B e-antigen (HBeAg) (RR 0.64, 95% CI 0.11 to 3.68; I² = 98%; 2 trials; 158 participants; very low-certainty evidence). Acupuncture showed a reduction in detectable hepatitis B virus (HBV) DNA (a non-validated surrogate outcome; RR 0.45, 95% CI 0.27 to 0.74; 1 trial, 58 participants; very low-certainty evidence). We are uncertain whether acupuncture has an effect regarding the remaining separately reported adverse events considered not to be serious.Three of the eight included trials received academic funding from government or hospital. None of the remaining five trials reported information on funding., Authors' Conclusions: The clinical effects of acupuncture for chronic hepatitis B remain unknown. The included trials lacked data on all-cause mortality, health-related quality of life, serious adverse events, hepatitis-B related mortality, and hepatitis-B related morbidity. The vast number of excluded trials lacked clear descriptions of their design and conduct. Whether acupuncture influences adverse events considered not to be serious is uncertain. It remains unclear if acupuncture affects HBeAg, and if it is associated with reduction in detectable HBV DNA. Based on available data from only one or two small trials on adverse events considered not to be serious and on the surrogate outcomes HBeAg and HBV DNA, the certainty of evidence is very low. In view of the wide usage of acupuncture, any conclusion that one might try to draw in the future should be based on data on patient and clinically relevant outcomes, assessed in large, high-quality randomised sham-controlled trials with homogeneous groups of participants and transparent funding.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.